Arca
Skip to content
Tools
Tools

23andMe PGS Genetic Health Risk Report for BRCA1/BRCA2 (Selected Variants)

Cancer Predisposition Risk Assessment System. De Novo DEN170046, from 23AndMe, Inc. (Mountain View, CA). Product code QAZ, class 2.

As of Nov 22, 2026, DEN170046 is an FDA De Novo held by 23AndMe, Inc., granted on Mar 6, 2018 after 182 days, with no recalls tied to it in FDA's recall database.

  • Review time: 182 days
  • Recalls: 0
  • Cited as a predicate by: 3 devices

Indications for use

As the 510(k) summary states them, read from FDA's summary PDF

The 23andMe Personal Genome Service (PGS) uses qualitative genotyping to detect select clinically relevant variants in genomic DNA isolated from human saliva collected from individuals ≥18 years with the Oragene Dx model OGD500.001 for the purpose of reporting and interpreting genetic health risks, including the 23andMe PGS Genetic Health Risk Report for BRCA1/BRCA2 (Selected Variants).

Pivotal study

The main clinical evidence FDA relied on, as its decision summary describes it
Design
Retrospective or analytical accuracy comparison of saliva genotyping vs. Sanger sequencing for three BRCA variants (specific study design not stated in text)
Primary endpoint
Positive percent agreement and negative percent agreement vs. Sanger sequencing for BRCA1 185delAG, BRCA1 5382insC, and BRCA2 6174delT
Result
Per-variant PPA of 100% for 5382insC heterozygous (45/46 concordant, 95% CI 92.1-100); other variant details not fully stated in trimmed text

Cited as a predicate

3 later 510(k) summaries name this device as a predicate

Other QAZ clearances

The newest 510(k)s for the same product code; see every QAZ device

Record

Type
Direct
Received
Sep 5, 2017
Review panel
Medical Genetics
Regulation
21 CFR 866.6090

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.